Merck inaugurates USD 550 million research facility: stock pre-market at EUR 129.52
Published on 10/16/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResearch investment and trading
- Merck inaugurated its ADVANCE facility on October 14, 2026, as part of a USD 550 million Pennsylvania investment.
- Merck & Co. stock traded pre-market at EUR 129.52 at 7:47 a.m. CEST on October 16, 2026, at Lang & Schwarz.
- The West Point campus has been part of Merck’s operations since 1953.
Merck & Co. inaugurated its ADVANCE bioanalytical research facility at the company’s West Point, Pennsylvania, campus on October 14, 2026. Merck said the project forms part of an approximately USD 550 million investment in research and development facilities at ADVANCE and the nearby Spring House Innovation Park. Merck.com published the company’s announcement.
Pre-market trading
Merck & Co. stock traded at EUR 129.52 at Lang & Schwarz at 7:47 a.m. CEST on October 16, 2026. The bid was EUR 129.34 and the ask was EUR 129.70. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Merck & Co. stock.
Facility and campus
Merck described ADVANCE as a facility using automated robotic systems and digital artificial-intelligence capabilities to support analysis of biological samples from clinical development programs. The company said its 400-acre West Point campus is its largest integrated research and human-health manufacturing site. Merck’s operations there date back to 1953, and the company said it has invested more than USD 15 billion at the site over the past 35 years. Merck.com provided the facility and investment details.
Market context: Market report S&P 500.
